McNeil discontinues Arthritis Foundation pain relievers line.
This article was originally published in The Tan Sheet
McNEIL DISCONTINUING ARTHRITIS FOUNDATION PAIN RELIEVERS LINE after the products "failed to achieve sales objectives," the J&J unit said. McNeil announced on Sept. 26 that it is replacing its former arrangement with the Arthritis Foundation -- in which it donated about $1 mil. a year to the foundation based on royalties on Arthritis Foundation product sales -- with an outright contribution of $1.3 mil. a year in 1997, 1998 and 1999. The funds are to be used for arthritis education and service programs.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC